What is the size of the Global Molecular Diagnostics Market?

The Global Molecular Diagnostics Market was valued at USD 11.6 billion in 2022 and is projected to reach a market size of USD 22.5 billion by the end of 2030, indicating a substantial CAGR of 8.633% during the forecast period of 2023-2030.

What are the Global Molecular Diagnostics Market drivers?

Advancements in technology, the rising prevalence of chronic diseases, personalized medicine and targeted therapies, and government initiatives and funding are key drivers.

What are the segments under the Global Molecular Diagnostics Market by Technology?

The market is segmented into polymerase chain reaction, next-generation sequencing, microarrays, isothermal nucleic acid amplification technology, and others.

Which region dominates the Global Molecular Diagnostics Market?

North America dominates the Global Molecular Diagnostics Market.

Who are the key players in the Global Molecular Diagnostics Market?

Roche Diagnostics, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Hologic, Inc., Danaher Corporation, Siemens Healthineers, Agilent Technologies, Grifols, and Myriad Genetics are among the key players in the market.